Home / Intelligence

Type
  • All
  • Analyst Reports
  • Blog
  • Briefs
  • Case Studies
  • Podcasts
  • Scientific Publications
  • Webinars
  • White Papers
Featured Topic
  • All
  • AIML
  • Analytics
  • APAC
  • Benchmarking
  • Biosimilars
  • CAR-T
  • Cell and Gene Therapy
  • Commercial Operations
  • Competitive Intelligence
  • Contract Analytics
  • Corporate Strategy
  • COVID-19
  • Customer Engagement
  • Data Management
  • Digital Therapeutics
  • Diversity
  • Emerging Life Sciences
  • Europe
  • Evidence Strategy (HEOR)
  • Field Force
  • Forecasting
  • Generative AI
  • Incentive Compensation
  • Inflation Reduction Act
  • Insights
  • International
  • LatAm
  • Launch and Brand Excellence
  • Learning and Development
  • Market Research
  • Marketing
  • Medical Affairs
  • MedTech
  • New Product Planning
  • NRDL
  • Omnichannel
  • Oncology
  • Patient Centricity
  • Patient Finding
  • Patient Services
  • Performance Tracking
  • Pricing and Access
  • Product Demos
  • Rare Disease
  • Real-World Evidence
  • Scientific Publications
  • Sustainability
  • Talent Acquisition and Retention
  • United States
  • Value Communication
Search
Robotic hand playing chess

White Papers

Predicting Winners: AI-Powered Portfolio Management

Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry? Not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for >90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%).

Read Now

Blog

Seizing the Storm: Why Pharma Must Plan, Not Panic in Trump’s Second Term

Published April 29, 2025

The first 100 days of President Trump’s return to the White House have been anything but ordinary. With a true “Flood the Zone” strategy, there has been a flurry of executive orders, leadership reshuffles, and a re-assertion of executive power, which has signaled the administration is interested in seeing what policy options can “stick.” While campaign rhetoric once suggested bold de-regulation with the potential for an industry-friendly reset, the governing reality has been less coherent and opens multiple fronts for…

Read Now

Webinars

The NRDL Conundrum: Balancing Between Access and Pricing for Innovation

May 21, 2025 | 1:00 - 1:45 PM ET

Two additional sessions will be offered: May 22 – 12:00 – 12:45 (UTC +8:00) – Asia/Shanghai May 22 – 12:00 – 12:45 CET – Europe/Berlin  What key insights emerged from the 2024 China National Reimbursement Drug List (NRDL) negotiations and how can they inform strategic go-to-market planning for innovative therapies? In the 2024 NRDL negotiations, only 28% of submitted products passed expert review, significantly raising the bar for entering pricing negotiations. However, products with robust clinical differentiation or superiority can…

Sign Up Now

Blog

Navigating the CRM Split: Generating Buy‑In

Published April 22, 2025

The transition to a new CRM system is more than just a technical migration; it’s a strategic choice that requires careful consideration and a strong point of view on what your organization needs for success.   To navigate the CRM transition necessitated by the Salesforce-Veeva split, it’s crucial to generate buy-in from account and field teams to ensure alignment and CRM utilization during and after the transition.   Interested in learning more about the Salesforce-Veeva split? Read our first blog here. Strategies…

Read Now

White Papers

Predicting Winners: AI-Powered Portfolio Management

Can artificial intelligence and machine learning (AIML) be used to support portfolio decision-making across the life sciences industry? In this installment of our Industry Impact Series, we find that not only can the latest AIML techniques identify the drivers of success and failure in commercialization, but Trinity Life Sciences’ AI algorithm accurately predicts revenue outcomes for >90% of U.S. drug launches, far exceeding the accuracy of Wall Street analyst consensus at the time of launch (<60%). Trinity’s AI algorithm incorporates publicly…

Read Now

Webinars

Health Equity in HTA Outcomes: Navigating the New Frontier

Available On Demand

Join Value, Access and Pricing experts Max Hunt, Mary Fletcher-Louis and Pinar Bilir as they delve into the emerging role of health equity considerations as a differentiator in value narratives for global HTA (Health Technology Assessment) submissions. NICE’s proposed methods update focused on manufacturer-submitted evidence on health inequalities.This session will explore how HTA agencies are beginning to include health equity in their access recommendations and discuss the practical impact of this trend. Our experts will share insights from Trinity Life…

Watch Now

Blog

The Evolution of CRM in Life Sciences: Navigating the Split

Published April 8, 2025

A Massive Change in Customer Relationship Management (CRM) Software The split between Veeva and Salesforce marks a significant shift in the CRM landscape. Veeva is removing its CRM from the Salesforce cloud in September 2025 to focus on its “Veeva Vault” cloud solution for CRM. Veeva has communicated that it will maintain the current CRM product until September 2030 but will not be making any updates—and that it will absorb the cost of migration to the new Vault platform for…

Read Now

Analyst Reports

Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences

Everest Group report: AI-deas to Action: Operationalizing Generative AI in Life Sciences This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included. The report highlights several of Trinity’s key strengths, including: Life Sciences Industry Expertise Trinity has nearly 30 years of experience in the industry, providing evidence-based solutions to over 300 clients, including the global top 20 biopharma companies. This deep…

Read Now

Blog

Trinity Life Sciences & Snowflake: Advancing Pharmaceutical Insights

Published March 27, 2025

Trinity Life Sciences and Snowflake recently released an exciting blog highlighting a case study that illustrates how their partnership built the data foundation for Trinity RealWorldEDGE and Real Insights. These offerings enable clients to quickly and easily access patient-level data from any source for insight generation–and allow clients to unlock the potential of predictive insights grounded in market research and real-world data. Excerpt How did Snowflake and Snowpark transform Trinity’s vision into reality? Data collaboration is critical to the success…

Read Now

Blog

Medical Affairs Customer Engagement: What’s Next?

Published March 19, 2025

Medical Affairs teams are increasingly harnessing the power of omnichannel communication and orchestrated customer engagement to enhance interactions with key stakeholders. Changing customer preferences and access to content are key factors Medical Affairs teams are addressing by adopting more customer engagement channels. As these capabilities continue to expand, it is important for teams to embrace a strategic mix of field medical engagements, digital platforms, personalized messaging, non-personal engagement and seamless coordination across channels. By adopting an omnichannel strategy, Medical Affairs…

Read Now

Webinars

Launch & Learn: Trinity Launch Accelerator

Available On Demand

Today’s launch environment is fraught with greater complexity, lack of standardization and executional inefficiency. Join Trinity Life Sciences for a virtual “launch and learn” where Krista Perry—Partner & Head of Launch Excellence and Tarra Maeshima— Sr. Director of New Products & Strategy share how Trinity Launch Accelerator enables teams to overcome these typical launch barriers with a simple and clear launch readiness and management process. Trinity’s Launch Accelerator is the industry’s first and only benchmark-based launch tool, built by experts…

Watch Now

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.